Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (293 IgG) | # Peptides (by Search Engine): B2 Sequest HT (293 Sel1L KO) | # Peptides (by Search Engine): C2 Sequest HT (293 WT) | # Peptides (by Search Engine): D2 Sequest HT (293 H KO) | # PSMs (by Search Engine): A2 Sequest HT (293 IgG) | # PSMs (by Search Engine): B2 Sequest HT (293 Sel1L KO) | # PSMs (by Search Engine): C2 Sequest HT (293 WT) | # PSMs (by Search Engine): D2 Sequest HT (293 H KO) | Abundance: F1: Sample, 293 IgG | Abundance: F2: Sample, 293 Sel1L KO | Abundance: F3: Sample, 293 WT | Abundance: F4: Sample, 293 H KO | Abundances Count: F1: Sample, 293 IgG | Abundances Count: F2: Sample, 293 Sel1L KO | Abundances Count: F3: Sample, 293 WT | Abundances Count: F4: Sample, 293 H KO | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | Q99661 | Kinesin-like protein KIF2C OS=Homo sapiens OX=9606 GN=KIF2C PE=1 SV=2 | 0 | 26.718 | 15 | 8 | 9 | 6 | 725 | 81.3 | 7.83 | 8 | 9 | 14950057.63 | 4 | cell division;cell organization and biogenesis;cell proliferation;cellular component movement;regulation of biological process;transport | chromosome;cytoplasm;cytoskeleton;cytosol;membrane;nucleus | catalytic activity;DNA binding;motor activity;nucleotide binding;protein binding | Pf00225 | 11004 | ENSG00000142945.12 | KIF2C | 1 | COPI-dependent Golgi-to-ER retrograde traffic; Kinesins; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; MHC class II antigen presentation | 0 |